REGN3500

Rivals’ disappointing results in asthma trial drag down shares of Anaptys Bio
Stat
Fri, 06/21/19 - 10:00 am
Sanofi
Regeneron
IL-33
asthma
monoclonal antibodies
REGN3500
AnaptysBio
Dupixent